肺癌長期位居臺灣癌症死亡首位，反映的不僅是疾病本身所延伸的重大負擔，更揭示整體醫療體系在早期偵測、治療整合與品質管理上的挑戰。隨著低劑量電腦斷層篩檢與精準醫療的進展，臺灣肺癌的流行病學樣貌與照護模式正快速演變。為因應此趨勢，財團法人醫院評鑑暨醫療品質策進會（醫策會）推動之肺癌照護品質認證，為我國建立跨領域整合、以病人為中心的肺癌照護新典範。疾病照護品質認證以「結構—過程—結果」為核心架構，強調多專科協作、個案管理制度化、標準化流程與共享決策，並透過臨床指標監測與持續改善機制，推動品質文化的內化與制度化。本文旨在從流行病學現況出發，解析疾病照護品質認證的核心理念與實務價值，展現台灣肺癌照護邁向標準化、可近化與人性化的新里程碑。

Lung cancer has long ranked as the leading cause of cancer-related death in Taiwan, reflecting not only the considerable burden imposed by the disease itself but also highlighting the challenges faced by the healthcare system in early detection, integrated treatment, and quality management. Following advancements in low-dose computed tomography screening and precision medicine,both the epidemiological landscape and care models of lung cancer in Taiwan are rapidly evolving. In response to this trend, the Joint Commission of Taiwan has launched the Disease Specific Care- Lung Cancer(DSC-LC) certification program, establishing a new patient-centered paradigm for integrated, multidisciplinary lung cancer care in Taiwan. The DSC is built upon the core framework of “structure–process–outcome”, emphasizing multidisciplinary collaboration, institutionalized case management, standardized procedures, and shared decision making. Through clinical indicator monitoring and continuous improvement mechanisms, it promotes the internalization and institutionalization of a quality-oriented culture. This study examined the current epidemiological context and elucidated the core concepts and practical values of the DSC, marking a new milestone in Taiwan’s pursuit of standardized, accessible, and patient-centered lung cancer care.